Cardinal Health's CFO attributes a 300 basis point increase in pharma guidance to strong Q1 performance and managing customer transition well. The Medical segment is expected to improve each quarter, focusing on executing GMPD improvement plan. GLP-1 inventory fluctuations have no significant impact on cash flow.